WHO guidelines for the management of postpartum haemorrhage ...

WHO guidelines for the management of postpartum haemorrhage and retained placenta
Acknowledgements
This document was prepared by Dr A. Metin Gülmezoglu, Dr João Paulo Souza and Dr Doris Chou (WHO Department
of Reproductive Health and Research), Dr Matthews Mathai (WHO Department of Making Pregnancy Safer),
Dr Suzanne Hill (WHO Essential Medicines and Pharmaceutical Policies) and Dr Edgardo Abalos (Centro Rosarino
de Estudios Perinatales, Rosario, Argentina), on the basis of discussions at the WHO Technical Consultation on
the Management of Postpartum Haemorrhage and Retained Placenta, held in Geneva on 18–21 November 2008.
The document was finalized after consideration of all comments and suggestions from the participants of the
Consultation to earlier drafts and an internal WHO review.
WHO gratefully acknowledges the contributions of the Chair of the Consultation (Dr Pisake Lumbiganon) and of
the international panel of experts who provided input to the Consultation. The assistance of Centro Rosarino de
Estudios Perinatales, Rosario, Argentina, and of Ms Mary Ellen Stanton are also gratefully acknowledged.
The process leading to the preparation of these guidelines was financially supported by the WHO Department of
Reproductive Health and Research and the United States Agency for International Development (USAID).
WHO Secretariat will review the questions below in the update of this guideline planned for 2010–2011.
Declarations of interest
Six temporary advisors (Hany Abdel-Aleem, Jennifer Blum, Richard Derman, Justus Hofmeyr, Pisake Lumbiganon
and Tran Son Thach) and one observer (Beverly Winikoff) declared that they had received grants for conducting
research and made presentations on the research they conducted regarding the use of misoprostol and other
aspects of PPH prevention and management which were reviewed during the meeting. None of these grants was
from commercial entities. One observer, Ms Mary Ellen Stanton, declared that she may present an organization’s
position (USAID) if required in this field.
The interests declared reflect the academic interest and opinions of the experts and the Secretariat does not
believe that there are any undeclared commercial or financial interests among the guideline review group.
The two observers did not participate in the voting processes and were not asked to approve or provide comments
to the document.
iv